Indusil (Cobamamide)

Cobamamide (methylcobalamin) acts as a coenzyme for methionine synthase and methylmalonyl‑CoA mutase, enzymes that are essential for DNA synthesis, fatty‑acid metabolism, and myelin formation, thereby supporting hematologic and neurologic functions.

The appropriate dose of Indusil is determined by a qualified healthcare professional based on the individual’s clinical condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not self‑adjust the dosage.

Safety data for cobamamide in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential benefits and risks with their healthcare provider before using Indusil.

To order Indusil, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Indusil provides cobamamide, the methylated, biologically active form of vitamin B12, which may be more readily utilized by the body compared with cyanocobalamin. This can be advantageous for patients with impaired conversion pathways, though clinical choice depends on individual needs and physician recommendation.

Indusil should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children.

Indusil is taken orally, usually with water. It can be taken with or without food, unless otherwise directed by a healthcare professional.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, thrombocytopenia, and significant hepatic or hematologic abnormalities. Immediate medical attention is required if any of these occur.

Individuals with known hypersensitivity to cobamamide or any excipients in the tablet should avoid Indusil. Patients with severe renal impairment or those taking medications that may interact significantly should consult a healthcare professional before use.